United States Biotechnology & Medical Research

Dermata Therapeutics Inc (DRMA)

Dermata Therapeutics Inc has recorded no insider trading activity within the past ninety days. The most recent transaction occurred on June 16, 2026, involving a minor sale of shares. Prior historical filings include various purchases by executives, though these events occurred well beyond the three-month window.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: DRMA Exchange: NAS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Dermata Therapeutics Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

3.0

Scott Kathleen D. Non-Executive Director

Transaction date 16 Jun 2026

Sale

Price

413.73

Quantity 38,783 +4.5%

Value US$2,883,722

1.5

Bedoya-Toro Munera Maria E SVP, Regulatory Affairs Officer

Transaction date 17 Feb 2026

Purchase

Price

454.64

Quantity 44,325 -40.1%

Value US$2,074,107

0.5

PROEHL GERALD T President, CEO and Chairman Executive Director Large shareholder

Transaction date 23 Nov 2021

Purchase

Price

241.80

Quantity 62,440 -20.6%

Value US$2,337,879

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-16	2026-06-16	S Sale	3.0 Scott Kathleen D. Non-Executive Director	38,783 +4.5% 413.73 US$2,883,722	38,783 +4.5%	413.73	US$2,883,722
2026-03-17	2026-02-17	B Purchase	1.5 Bedoya-Toro Munera Maria E SVP, Regulatory Affairs Officer	44,325 -40.1% 454.64 US$2,074,107	44,325 -40.1%	454.64	US$2,074,107
2021-11-26	2021-11-23	B Purchase	0.5 PROEHL GERALD T President, CEO and Chairman Executive Director Large shareholder	62,440 -20.6% 241.80 US$2,337,879	62,440 -20.6%	241.80	US$2,337,879